University of Ioannina
Μέτρηση βιολογικών δεικτών σε ασθενείς με σχιζοφρένεια πριν και μετά τη θεραπεία με κλοζαπίνη
Abstract
dc:descriptionAt late 90s the , the hypothesis of the involvement of immune factors in the induction of schizophrenia gained ground, through the research for inflammatory factors, primarily cytokines, in the peripheral blood but also much more rarely in the cerebrospinal fluid of patients with schizophrenia. The cytokine hypothesis in schizophrenia would be formulated in the early 2000s, enriched and modified leading to the microglia hypothesis in schizophrenia. At the same time, the reintroduction of clozapine after its approval by the US Food and Drug Administration in 1992 raises expectations for the treatment of schizophrenia cases unresponsive to treatment with other antipsychotics. Interest in clozapine increases even more when, despite the discovery of second-generation antipsychotics in the 1990s-2010s, treatment-resistant cases remain in at least 15-20% of patients. At the same time, interest in controlling antipsychotic drug concentrations and particularly of clozapine increases with the aim of more rational dosing of medication, avoiding toxic or subtherapeutic concentrations, reducing hospitalization time, monitoring adherence to medication, evaluating the effectiveness of treatment. 1. In our study we found higher values of adiponectin, leptin and resistin in treatment-naïve first episode psychotic patients with normal BMI compared to age, sex, BMI and smoking-matched controls. Six weeks after antipsychotic treatment with olanzapine or risperidone, adiponectin and resistin values did not show a statistically significant change, while leptin values decreased significantly. According to our findings, adiponectin, resistin and leptin appear to reflect subclinical metabolic disturbances and/or play a role in inflammatory processes occurring in the first psychotic episode. 2. We also found in first-episode patients who proved resistant to two atypical antipsychotics and were placed on clozapine, an increase in the anti-inflammatory cytokine interleukin-4 a after clozapine treatment, also an increase in resistin values while a statistically significant decrease was found of adiponectin values. The increase in the values of interleukin-4 seems to be related to the anti-inflammatory effect of clozapine, while the increase in resistin and the decrease in adiponectin may be related to subclinical metabolic disorders and/or to immune disorders of treatment resistant patients. treatment of patients with schizophrenia. Adiponectin and TGF-β levels showed a statistically significant reduction in this group of patients while resistin and IL-4 levels did not show any statistically significant change after risperidone and olanzapine treatment compared to the same values before the administration of any antipsychotic medication. 3. We further found a correlation of clozapine/norclozapine plasma levels with administered clozapine doses. Higher clozapine concentrations are associated with a longer DUP, possibly because these patients require higher doses of clozapine to achieve a therapeutic effect. Smoking status tended to be associated with lower plasma clozapine levels as 19.38% of nonsmokers had clozapine levels >750ng/ml versus 1.33% of smokers. This finding is in accordance with the finding of other studies. Of the 342 samples, in 237 (69.3% of the samples) clozapine concentrations were within the therapeutic range and in 16 samples (4.67%) high therapeutic range, in 1.75% (6 samples) of the samples were at toxic levels.
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2023
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Karampas, Andreas
- Καραμπάς, Ανδρέας
Subjects
dc:subject × 12Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/55022